ProCE Banner Activity

Congress to Clinic: Continual Evolution of HER3-Targeting in NSCLC With Expert Perspectives on Clinical Advances and Practical Application


Downloadable slides with a comprehensive review of the most recent data on HER3-targeted treatment strategies for patients with advanced NSCLC from a live event.

Released: November 17, 2023

Begin Activity



Rebecca S. Heist

Rebecca S. Heist, MD, MPH

Associate Professor of Medicine
Harvard Medical School
Medical Oncology
Massachusetts General Hospital
Boston, Massachusetts

Helena Yu

Helena Yu, MD

Associate Attending
Research Director of Thoracic Oncology Service
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, New York

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.